To the best of our knowledge, this is the first report to assess CRP levels in different forms of thyroid disease, which include toxic adenoma, hyperthyroidism and hypothyroidism subsequent to the use of drugs such as IFN-α and AM, and thyroid cancer patients. Here, IFNA2 is linked to hyperthyroidism.